French Public Familiarity and Attitudes toward Clinical Research during the Covid-19 Pandemic

The COVID-19 pandemic put clinical research in the media spotlight globally. This article proposes a first measure of familiarity with and attitude toward clinical research in France. Drawing from the "Health Literacy Survey 2019" (HLS19) conducted online between 27 May and 5 June 2020 on a sample of the French adult population (N = 1003), we show that a significant proportion of the French population claimed some familiarity with clinical trials (64.8%) and had positive attitudes (72%) toward them. One of the important findings of this study is that positive attitudes toward clinical research exist side by side with a strong distancing from the pharmaceutical industry. While respondents acknowledged that the pharmaceutical industry plays an important role in clinical research (68.3%), only one-quarter indicated that they trust the industry (25.7%). Positive attitudes toward clinical trials were associated with familiarity with clinical trials (Odds Ratio, OR 2.97 [1.90-4.63]), financial difficulties (OR 0.63 [0.46-0.85]), as well as mistrust of doctors (0.48 [0.27-0.85]) and of scientists (OR 0.62 [0.38-0.99]). Although the French media provided a great deal of information on how clinical research works during the first months of the pandemic, there remains profound mistrust of the pharmaceutical industry in France. This suspicion can undermine crisis management, especially in the areas of vaccine development and preparation for future pandemics

Clinical trial · Coronavirus disease 2019 (COVID-19 · Distancing · Environmental health · Family medicine · Geography · Health care · Health literacy · Literacy · Pandemic · Pathology · Pharmaceutical industry · Political science · Population · Public health · Public relations · Quarter (Canadian coin · Ethics in Clinical Research · Medicine · Nursing · Pharmaceutical industry and healthcare · Psychology · Vaccine Coverage and Hesitancy · Pharmacology

• Spillover Effects of Covid-19 News Coverage on Willingness to Participate in Medical Research in a Diverse Sample of US Older Adults

  Open Access•Amy Bleakley, Erin K Maloney et al.•Communication Research•2026

  Incluir item

• Entre santé et science

  Emily Schultz, Emilien Schultz et al.•Santé Publique•2024

  Incluir item

• Making Health Public

  Charles L Briggs, Daniel C Hallin•Making Health Public•2016

  Incluir item

• Applied Logistic Regression

  Open Access•David W Hosmer, David W Jr Hosmer et al.•Applied Logistic Regression•2013

  Incluir item

• Measuring trust in vaccination

  Open Access•Heidi J Larson, Richard M Clarke et al.•Human Vaccines & Immunotherapeutics•2018

  Incluir item

• Science-related populism

  Open Access•Niels G Mede, Mike S Schäfer•Public Understanding of Science•2020

  Incluir item

• The cultural authority of science

  Open Access•Gordon Gauchat•Public Understanding of Science•2011

  Incluir item

• False Hopes and Best Data

  Paul S Appelbaum, Peter Appelbaum et al.•The Hastings Center Report•1987

  Incluir item

• Cancer Clinical Trials

  P Keating, Alberto Cambrosio•Bulletin of the history of medicine•2007

  Incluir item

• Clinical trials as treatment option

  Open Access•Stefan Timmerman, Tara Mckay•Social Science & Medicine•2009

  Incluir item

• Politicization of Science in the Public Sphere

  Open Access•Gordon Gauchat•American Sociological Review•2012

  Incluir item

• Une médecine détournée ? Influences industrielles et crise de confiance dans le domaine du médicament

  Boris Hauray•Mouvements•2019

  Incluir item

• New forms of competition in higher education1

  Open Access•Christine Musselin•Socio-Economic Review•2018

  Incluir item

• Hydroxychloroquine Controversies

  Open Access•Luc Berlivet, Ilana Löwy•Medical Anthropology Quarterly•2020

  Incluir item

• The many meanings of care in clinical research

  Open Access•Michele M Easter, Gail E Henderson et al.•Sociology of Health & Illness•2006

  Incluir item